Innospec earnings were $27.0M for the trailing 12 months ending Mar 31, 2025, with -81.8% growth year over year. The latest IOSP earnings report on Mar 31, 2025 announced Q1 2025 earnings of $32.8M, down 146.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IOSP reported annual earnings of $35.6M, with -74.4% growth.
IOSP past earnings growth
How has IOSP's earnings growth performed historically?
On IOSP's earnings call on Invalid Date, Innospec (NASDAQ: IOSP) reported Q1 2025 earnings per share (EPS) of $1.31, up 21.08% year over year. Total IOSP earnings for the quarter were $32.80 million. In the same quarter last year, Innospec's earnings per share (EPS) was $1.66.
As of the last Innospec earnings report, Innospec is currently profitable. Innospec's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $27.00 million, a 81.67% decrease year over year.
What was IOSP's earnings growth in the past year?
As of Innospec's earnings date in Invalid Date, Innospec's earnings has grown -81.76% year over year. This is 88.46 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 6.7%. IOSP earnings in the past year totalled $27.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.